Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNK | O75909 | 8/20 | 0.61 |
| ▸ | CDK12 | Q9NYV4 | 8/20 | 0.61 |
| ▸ | CCNT1 | O60563 | 7/20 | 0.61 |
| ▸ | CDK9 | P50750 | 7/20 | 0.61 |
| ▸ | CCNE1 | P24864 | 6/20 | 0.61 |
| ▸ | CDK2 | P24941 | 6/20 | 0.61 |
| ▸ | CHEK1 | O14757 | 6/20 | 0.60 |
| ▸ | CDK7 | P50613 | 3/20 | 0.59 |
| ▸ | CCNH | P51946 | 3/20 | 0.59 |
| ▸ | MNAT1 | P51948 | 3/20 | 0.59 |
| ▸ | FLT3 | P36888 | 2/20 | 0.56 |
| ▸ | ULK1 | O75385 | 2/20 | 0.55 |
| ▸ | IDH2 | P48735 | 1/20 | 0.54 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | SYK | P43405 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31666582 | 1.00 | CCNK (0.61) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL30260876 | 0.89 | CHEK1 (0.58) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL30261007 | 0.87 | ULK1 (0.65) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL30260881 | 0.86 | CCNK (0.55) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL31666623 | 0.86 | CCNT1 (0.57) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL30260956 | 0.86 | CCNK (0.57) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL31666785 | 0.86 | CCNT1 (0.57) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL30261059 | 0.85 | CCNK (0.56) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL30260800 | 0.85 | CCNK (0.54) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL31666782 | 0.84 | CCNK (0.60) | CCNKCDK12CCNT1CDK9CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137698-A1 | CYCLIN-DEPENDENT KINASE 7 INHIBITORS | JOINT STOCK CO «BIOCAD» (RU) | 2026-05-21 | — | — | US | claimed |
| EP-4592283-A1 | CYCLIN-DEPENDENT KINASE 7 INHIBITORS | Joint Stock Company "Biocad" (RU) | 2025-07-30 | — | — | EP | claimed |
| EP-4592283-A1 | CYCLIN-DEPENDENT KINASE 7 INHIBITORS | Joint Stock Company "Biocad" (RU) | 2025-07-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137698-A1 | CYCLIN-DEPENDENT KINASE 7 INHIBITORS | CDK7, CDK6, CDK3 | CCNK 13/4885CDK12 63/4885CCNT1 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.